- Home
- PRME vs MGIC Comparison
PRME vs MGIC Comparison
Compare PRME & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- MGIC
- Stock Information
- Founded
- PRME 2019
- MGIC 1983
- Country
- PRME United States
- MGIC Israel
- Employees
- PRME N/A
- MGIC N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- MGIC Computer Software: Prepackaged Software
- Sector
- PRME Health Care
- MGIC Technology
- Exchange
- PRME Nasdaq
- MGIC Nasdaq
- Market Cap
- PRME 424.9M
- MGIC N/A
- IPO Year
- PRME 2022
- MGIC 1991
- Fundamental
- Price
- PRME $2.70
- MGIC $12.20
- Analyst Decision
- PRME Strong Buy
- MGIC Buy
- Analyst Count
- PRME 9
- MGIC 1
- Target Price
- PRME $13.13
- MGIC $15.00
- AVG Volume (30 Days)
- PRME 1.1M
- MGIC 37.2K
- Earning Date
- PRME 02-28-2025
- MGIC 03-12-2025
- Dividend Yield
- PRME N/A
- MGIC 1.68%
- EPS Growth
- PRME N/A
- MGIC N/A
- EPS
- PRME N/A
- MGIC 0.70
- Revenue
- PRME $800,000.00
- MGIC $535,482,999.00
- Revenue This Year
- PRME N/A
- MGIC $4.29
- Revenue Next Year
- PRME $426.55
- MGIC $3.39
- P/E Ratio
- PRME N/A
- MGIC $16.95
- Revenue Growth
- PRME N/A
- MGIC N/A
- 52 Week Low
- PRME $2.56
- MGIC $9.51
- 52 Week High
- PRME $9.77
- MGIC $13.40
- Technical
- Relative Strength Index (RSI)
- PRME 39.60
- MGIC 55.29
- Support Level
- PRME $2.74
- MGIC $11.36
- Resistance Level
- PRME $3.59
- MGIC $12.24
- Average True Range (ATR)
- PRME 0.23
- MGIC 0.23
- MACD
- PRME 0.00
- MGIC -0.02
- Stochastic Oscillator
- PRME 7.29
- MGIC 89.83
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.